Amgen (AMGN) operating cash flow was $10.0B in FY2025 (-13% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$10.0B
-13%
2024
$11.5B
+36%
2023
$8.5B
-13%
2022
$9.7B
+5%
2021
$9.3B
-12%
2020
$10.5B
+15%
2019
$9.2B
-19%
2018
$11.3B
+1%
2017
$11.2B
+8%
2016
$10.4B
+6%
2015
$9.7B
+9%
2014
$9.0B
+42%
2013
$6.3B
+7%
2012
$5.9B
+15%
2011
$5.1B
-12%
2010
$5.8B
-9%
2009
$6.3B
+6%
2008
$6.0B
+11%
2007
$5.4B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q1 2026
$2.2B
Q4 2025
$1.6B
Q3 2025
$4.7B
Q2 2025
$2.3B
Q1 2025
$1.4B
Q4 2024
$4.8B
Q3 2024
$3.6B
Q2 2024
$2.5B
Q1 2024
$689M
Q4 2023
$538M
Q3 2023
$2.8B
Q2 2023
$4.1B
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.